Rifaximin potentiates clarithromycin against Mycobacterium abscessus in vitro and in zebrafish
Mycobacterium abscessus is a non-tuberculous mycobacterium (NTM) that causes chronic pulmonary infections. Because of its extensive innate resistance to numerous antibiotics, treatment options are limited, often resulting in poor clinical outcomes. Current treatment regimens usually involve a combin...
Saved in:
Main Authors: | Goh, Boon Chong, Larsson, Simon, Dam, Linh Chi, Ling, Sharon Yan Han, Chua, Patrina Wei Lin, Abirami, R., Singh, Samsher, Ong, Ernest Jun Long, Teo, Jeanette W. P., Ho, Peiying, Ingham, Philip William, Pethe, Kevin, Dedon, Peter C. |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/173643 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Vancomycin and clarithromycin show synergy against Mycobacterium abscessus in vitro
by: Mukherjee, D, et al.
Published: (2020) -
Rifabutin suppresses inducible clarithromycin resistance in mycobacterium abscessus by blocking induction of whiB7 and erm41
by: Aziz, D.B., et al.
Published: (2021) -
Drug discovery to reverse clarithromycin resistance in multidrug-resistant mycobacterium abscessus
by: Dam, Linh Chi
Published: (2019) -
Rifabutin Is active against mycobacterium abscessus complex
by: Aziz, D.B, et al.
Published: (2020) -
Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish
by: Dupont, Christian, et al.
Published: (2018)